DESCRIBE <http://purl.uniprot.org/SHA-384/84F31A2B207B934E1FC45D47FE5A55421ECF4D529E50C52307213575A86BDD31A703F4133EA98372C63720CD393B1C18>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/84F31A2B207B934E1FC45D47FE5A55421ECF4D529E50C52307213575A86BDD31A703F4133EA98372C63720CD393B1C18	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/84F31A2B207B934E1FC45D47FE5A55421ECF4D529E50C52307213575A86BDD31A703F4133EA98372C63720CD393B1C18	http://www.w3.org/2000/01/rdf-schema#comment	"Galectin 9 is a novel dectin 1 ligand in pancreatic ductal adenocarcinoma. Upon disruption of the dectin 1-galectin 9 axis CD4(+) and CD8(+) T cells which are dispensable for PDA progression in hosts with an intact signaling axis become reprogrammed into indispensable mediators of anti-tumor immunity."xsd:string
http://purl.uniprot.org/uniprot/#_78732DDA2504D3B88C882BC78A6840202F74618E4BB2F94F1A4922A9E9DCEE010D2DA5EC5B3C2C038FC30D0A01C96055	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/84F31A2B207B934E1FC45D47FE5A55421ECF4D529E50C52307213575A86BDD31A703F4133EA98372C63720CD393B1C18
http://purl.uniprot.org/uniprot/O08573	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/84F31A2B207B934E1FC45D47FE5A55421ECF4D529E50C52307213575A86BDD31A703F4133EA98372C63720CD393B1C18
http://purl.uniprot.org/uniprot/#_O08573-mappedCitation-28394331	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/84F31A2B207B934E1FC45D47FE5A55421ECF4D529E50C52307213575A86BDD31A703F4133EA98372C63720CD393B1C18